91探花

Our CEO gives his take on what's in store for the biotech industry in 2023 as part of this forward looking feature.

This series explores the fascinating interface between science and design. Episode 2 looks at synthetic biology and features our ...

91探花 founder and CEO Dr Mark Kotter has 15 minutes to explain how we program biology as software to develop affordable next gen...

New advisors will provide important and independent guidance.

91探花 aim to address the translation gap and accelerate research and drug discovery for neurodegenerative disease.

91探花 received a bronze award for its participation in the Green Impact awards for sustainability.

91探花鈥檚 Founder and former CEO Dr Mark Kotter on creating every cell type and kickstarting a cell therapy revolution.

91探花 is supporting the iGEM team from University of Cambridge in the iGEM synbio competition.